Literature DB >> 26848819

Novel application of high-dose rate brachytherapy for severe, recalcitrant palmoplantar pustulosis.

D Timerman1, P M Devlin2, V E Nambudiri3, N A Wright3, R A Vleugels3, R A Clark3, T S Kupper3, J F Merola3,4, M Patel3.   

Abstract

Palmoplantar pustulosis (PPP) is a chronic pustular dermatitis of the palms and soles, which is frequently associated with significant pruritus and pain, often limiting daily activities. We present the case of a 36-year-old man with severe PPP who had treatment failure with multiple medical therapies but showed marked improvement with high-dose rate brachytherapy. Brachytherapy has the advantage of providing a conformal dose distribution over complex curved surfaces, such as the foot and ankle. Our observations suggest that brachytherapy may be a well-tolerated treatment option for patients with severe, refractory PPP.
© 2016 British Association of Dermatologists.

Entities:  

Mesh:

Year:  2016        PMID: 26848819      PMCID: PMC5317041          DOI: 10.1111/ced.12803

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  7 in total

1.  Randomized clinical trials for psoriasis 1977-2000: the EDEN survey.

Authors:  Luigi Naldi; Ake Svensson; Thomas Diepgen; Peter Elsner; Jean-Jacques Grob; Pieter-Jan Coenraads; Jan Nico Bouwes Bavinck; Hywel Williams
Journal:  J Invest Dermatol       Date:  2003-05       Impact factor: 8.551

Review 2.  Management of palmoplantar pustulosis: do we need to change?

Authors:  U Mrowietz; P C M van de Kerkhof
Journal:  Br J Dermatol       Date:  2011-05       Impact factor: 9.302

3.  [History of roentgenotherapy in dermatology].

Authors:  R SCHMITZ
Journal:  Strahlentherapie       Date:  1950

4.  Complete remission of refractory dyshidrotic eczema with the use of radiation therapy.

Authors:  M D Stambaugh; A S DeNittis; P E Wallner; W R Heymann
Journal:  Cutis       Date:  2000-04

5.  Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

Authors:  Howa Yeung; Joy Wan; Abby S Van Voorhees; Kristina Callis Duffin; Gerald G Krueger; Robert E Kalb; Jamie D Weisman; Brian R Sperber; Bruce A Brod; Stephen M Schleicher; Bruce F Bebo; Daniel B Shin; Andrea B Troxel; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2012-07-28       Impact factor: 11.527

Review 6.  Ionizing radiation therapy in dermatology.

Authors:  H Goldschmidt; J C Breneman; D L Breneman
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

7.  Long-term results of radiotherapy in patients with chronic palmo-plantar eczema or psoriasis.

Authors:  Marcin Sumila; Markus Notter; Peter Itin; Stephan Bodis; Guenther Gruber
Journal:  Strahlenther Onkol       Date:  2008-04       Impact factor: 3.621

  7 in total
  3 in total

Review 1.  T cells and the skin: from protective immunity to inflammatory skin disorders.

Authors:  Allen W Ho; Thomas S Kupper
Journal:  Nat Rev Immunol       Date:  2019-08       Impact factor: 53.106

2.  Skin-directed radiation therapy for palmoplantar pustulosis.

Authors:  Brian J King; Andrea P Langeveld; Mark D P Davis; James A Martenson
Journal:  JAAD Case Rep       Date:  2019-05-21

3.  End-to-end test and MOSFET in vivo skin dosimetry for 192Ir high-dose-rate brachytherapy of chronic psoriasis.

Authors:  Lalida Tuntipumiamorn; Pitchayut Nakkrasae; Sansanee Kongkum; Pittaya Dankulchai
Journal:  J Contemp Brachytherapy       Date:  2019-08-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.